TrialDiabetes care2011

Exenatide twice daily versus premixed insulin aspart 70/30 in metformin-treated patients with type 2 diabetes: a randomized 26-week study on glycemic control and hypoglycemia.

Baptist Gallwitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.